Chromosome analysis: use of FISH data for prognosis58
Category . | % of Patients . | Median treatment-free interval, mo* . | Median survival, mo* . |
|---|---|---|---|
| 17p- | 7 | 9 | 32 |
| 11q- without 17p- | 17 | 13 | 79 |
| Trisomy 12 without 11q- or 17p- | 14 | 33 | 114 |
| Normal karyotype | 18 | 49 | 111 |
| 13q- as sole abnormality | 36 | 92 | 133 |
| Other abnormalities | 8 | — | — |
Category . | % of Patients . | Median treatment-free interval, mo* . | Median survival, mo* . |
|---|---|---|---|
| 17p- | 7 | 9 | 32 |
| 11q- without 17p- | 17 | 13 | 79 |
| Trisomy 12 without 11q- or 17p- | 14 | 33 | 114 |
| Normal karyotype | 18 | 49 | 111 |
| 13q- as sole abnormality | 36 | 92 | 133 |
| Other abnormalities | 8 | — | — |
— indicates heterogeneous group.
Median follow-up, 70 months.